Literature DB >> 8721156

Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression.

J L Labandeira-Garcia1, G Rozas, E Lopez-Martin, I Liste, M J Guerra.   

Abstract

Changes taking place after unilateral 6-hydroxydopamine lesion of the dopaminergic nigrostriatal system have been studied by performing spontaneous, amphetamine-induced and apomorphine-induced rotational behaviour testing and tyrosine hydroxylase (TH) and Fos protein immunohistochemistry in the same rats. Apomorphine at a low dosage (0.25 mg/kg) induced contraversive rotation and supersensitive striatal Fos expression that were detected 24-48 h post-lesion and gradually increased in magnitude. Twenty-four hours after lesion, both high (5 mg/kg) and low doses (0.5 mg/kg) of D-amphetamine induced contraversive rotation and intense striatal Fos activation on the denervated side; however, only the higher dose induced Fos on the normal side. Two, 3 and 4 days after lesion, 0.5 mg/kg amphetamine induced contraversive rotation, but 5 mg/kg induced transitory contraversive rotation which switched to ipsiversive. In the normal striatum, only high doses of amphetamine induced Fos, but Fos induction in the denervated striatum was similar with both doses: areas showing severely decreased TH immunoreactivity still showed considerable Fos immunoreactivity, and some areas still showing TH immunoreactivity had higher Fos density than in the normal side. Seven and 14 days after lesion the loss of TH immunoreactivity and apomorphine-induced supersensitive Fos expression were more evenly distributed, and amphetamine induced only ipsiversive rotation and a low density of Fos-positive nuclei in the denervated striatum. These results indicate that the severe and progressive loss of dopaminergic terminals is counteracted by an early and rapidly progressing dopamine supersensitivity, together with a higher susceptibility to drug-induced dopamine release. This explains the apparently paradoxical contraversive rotation induced by amphetamine during the first week post lesion. However, experiments involving successive drug injections indicated that only the first amphetamine injection releases dopamine from the lesioned terminals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8721156     DOI: 10.1007/BF00242905

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  48 in total

Review 1.  Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun.

Authors:  J I Morgan; T Curran
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

2.  Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.

Authors:  F Hefti; E Melamed; R J Wurtman
Journal:  Brain Res       Date:  1980-08-11       Impact factor: 3.252

3.  Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.

Authors:  I Creese; S H Snyder
Journal:  Eur J Pharmacol       Date:  1979-06-15       Impact factor: 4.432

4.  Rapid development of dopaminergic supersensitivity in reserpine-treated rats demonstrated with 14C-2-deoxyglucose autoradiography.

Authors:  J M Trugman; C L James
Journal:  J Neurosci       Date:  1992-07       Impact factor: 6.167

5.  D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.

Authors:  M L Paul; A M Graybiel; J C David; H A Robertson
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

6.  L-dopa stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors.

Authors:  M Morelli; A Cozzolino; A Pinna; S Fenu; A Carta; G Di Chiara
Journal:  Brain Res       Date:  1993-10-01       Impact factor: 3.252

7.  Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity.

Authors:  K A Neve; M R Kozlowski; J F Marshall
Journal:  Brain Res       Date:  1982-07-22       Impact factor: 3.252

8.  The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: multifactorial induction of outward transport.

Authors:  A Langeloh; H Bönisch; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

9.  Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.

Authors:  W Q Zhang; H A Tilson; K P Nanry; P M Hudson; J S Hong; M K Stachowiak
Journal:  Brain Res       Date:  1988-10-04       Impact factor: 3.252

10.  Intrastriatal grafts derived from fetal striatal primordia: II. Reconstitution of cholinergic and dopaminergic systems.

Authors:  F C Liu; A M Graybiel; S B Dunnett; R W Baughman
Journal:  J Comp Neurol       Date:  1990-05-01       Impact factor: 3.215

View more
  7 in total

1.  The phenylephrine blood pressure clamp in pharmacologic magnetic resonance imaging: reduction of systemic confounds and improved detectability of drug-induced BOLD signal changes.

Authors:  Raffael Kalisch; Marina Delfino; M Gustavo Murer; Dorothee P Auer
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

Review 2.  Using c-fos to study neuronal ensembles in corticostriatal circuitry of addiction.

Authors:  Fabio C Cruz; F Javier Rubio; Bruce T Hope
Journal:  Brain Res       Date:  2014-11-11       Impact factor: 3.252

3.  Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.

Authors:  Silvia Cerri; Rosaria Greco; Giovanna Levandis; Cristina Ghezzi; Antonina Stefania Mangione; Marie-Therese Fuzzati-Armentero; Arianna Bonizzi; Maria Antonietta Avanzini; Rita Maccario; Fabio Blandini
Journal:  Stem Cells Transl Med       Date:  2015-07-21       Impact factor: 6.940

4.  Rho kinase inhibitor fasudil reduces l-DOPA-induced dyskinesia in a rat model of Parkinson's disease.

Authors:  Andrea Lopez-Lopez; Carmen M Labandeira; Jose L Labandeira-Garcia; Ana Muñoz
Journal:  Br J Pharmacol       Date:  2020-11-03       Impact factor: 8.739

5.  Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats.

Authors:  A Muñoz; A Lopez-Real; J L Labandeira-Garcia; M J Guerra
Journal:  Exp Brain Res       Date:  2003-08-29       Impact factor: 1.972

Review 6.  How compensation breaks down in Parkinson's disease: Insights from modeling of denervated striatum.

Authors:  Charlotte Amalie Navntoft; Jakob Kisbye Dreyer
Journal:  Mov Disord       Date:  2016-02-18       Impact factor: 10.338

7.  L-dopa response pattern in a rat model of mild striatonigral degeneration.

Authors:  Christine Kaindlstorfer; Nadia Stefanova; Joanna Garcia; Florian Krismer; Máté Döbrössy; Georg Göbel; Kurt Jellinger; Roberta Granata; Gregor Karl Wenning
Journal:  PLoS One       Date:  2019-06-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.